Zynex Inc. (ZYXI)
NASDAQ: ZYXI
· Real-Time Price · USD
1.33
-0.06 (-4.32%)
At close: Oct 16, 2025, 3:59 PM
1.37
2.62%
After-hours: Oct 16, 2025, 07:17 PM EDT
-4.32% (1D)
| Bid | 1.33 |
| Market Cap | 40.45M |
| Revenue (ttm) | 144.81M |
| Net Income (ttm) | -28.66M |
| EPS (ttm) | -0.93 |
| PE Ratio (ttm) | -1.44 |
| Forward PE | -3.07 |
| Analyst | Hold |
| Dividends | n/a |
| Ask | 1.43 |
| Volume | 63,920 |
| Avg. Volume (20D) | 233,362 |
| Open | 1.38 |
| Previous Close | 1.39 |
| Day's Range | 1.32 - 1.40 |
| 52-Week Range | 1.23 - 9.42 |
| Beta | 1.10 |
| Ex-Dividend Date | n/a |
About ZYXI
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ZYXI
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ZYXI stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsZynex Inc. is scheduled to release its earnings on
Oct 27, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
-43.5%
Zynex shares are trading lower after the company r...
Unlock content with
Pro Subscription
2 months ago
-10.44%
Zynex shares are trading lower after the company reported worse-than-expected Q2 financial results.
1 day ago · proactiveinvestors.com
Zynex is an innovative medical technology company specializing in non-invasive pain management devicesDeep Dive - Zynex Inc
2 months ago · fool.com
Zynex Q2 Revenue Drops 55%Zynex Q2 Revenue Drops 55%
2 months ago · proactiveinvestors.com
Zynex eyes growth revival under new CEO, advances oximeter technologyZynex Inc (NASDAQ:ZYXI), a developer of non-invasive medical devices, is laying the foundation for a return to growth following a pivotal second quarter marked by leadership changes, operational strea...